Abnormal prenatal blood test results could indicate hidden maternal cancers
NIH study finds some abnormal results due to colorectal, breast, lung and pancreatic cancers
2024-12-04
(Press-News.org)
WHAT:
Researchers at the National Institutes of Health (NIH) found previously undetected cancers in 48.6% of pregnant people who had abnormal results for prenatal cell-free DNA (cfDNA) testing used to screen for chromosomal disorders in the fetus. Cancers included colorectal, breast, lung and pancreatic cancers, as well as lymphoma, cholangiocarcinoma and renal carcinoma. The screening test analyzes placental DNA fragments circulating in the maternal bloodstream to identify an extra chromosome or to determine the baby’s sex. The study appears in the New England Journal of Medicine.
In addition to fetal DNA, cfDNA testing detects DNA released from the mother’s red blood stem cells and, occasionally, abnormal DNA that may result from an undetected cancer in the asymptomatic pregnant person. NIH’s ongoing IDENTIFY study seeks to learn more about abnormal cfDNA test results that could indicate potential cancers. For the current analysis, researchers performed cancer screening of 107 IDENTIFY participants using whole body magnetic resonance imaging (MRI), standard medical diagnostic tests, and cfDNA sequencing. A total of 52 participants were diagnosed with cancer. For this group, the authors found that whole body MRI was the most effective method for detecting cancer. Standard diagnostic techniques, such as taking a medical history, assessing symptoms, and physical examination, were of limited use in identifying a participant’s cancer or its location.
Other abnormal cfDNA results were attributed to fibroids (benign uterine tumors), placental chromosomes that differed from fetal chromosomes, and clonal hematopoiesis in the mother (a precancerous state that can lead to blood cancers). The researchers noted the need for additional studies to validate cfDNA sequencing patterns described by the investigators that could indicate cancer in this young, pregnant population without obvious clinical symptoms.
The study was conducted by researchers in NIH’s National Human Genome Research Institute, National Cancer Institute, and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
WHO:
NICHD Director Diana W. Bianchi, M.D., the senior author of the paper, is available for comment.
ARTICLE:
Turriff AE et al. Prenatal cfDNA sequencing and incidental detection of maternal cancer. New England Journal of Medicine DOI: 10.1056/NEJMoa2401029 (2024)
###
About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD leads research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. For more information, visit https://www.nichd.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-12-04
DETROIT (Dec. 04, 2024)—Losing weight with anti-obesity medications (AOM) also resulted in decreased alcohol consumption for about half of the participants in a new study appearing in the current issue of JAMA Network Open.
The research, led by Lisa Miller-Matero, PhD, an associate scientist and Associate Director of Health Services Research at Henry Ford Health, adds to a growing body of research that suggests medications such as Ozempic or Wegovy could be adapted to treat substance use disorders.
“This was different ...
2024-12-04
The U.S. Department of Defense has awarded the ETSU Research Corporation over $900,000 as part of the Defense Industrial Base Consortium, an investment that will help create new opportunities to foster regional innovation in sustainable industrial manufacturing in the Appalachian region.
“Our goal is to enhance the prosperity of our region by connecting local innovation with opportunities in global emerging markets,” said Eric Jorgenson, vice president of evelopment for the ETSU Research Corporation. “This project is another key part of the foundation of a robust biomanufacturing ecosystem in ...
2024-12-04
An East Tennessee State University researcher is developing a cutting-edge dashboard using generative artificial intelligence to assist in monitoring flooding in Central Appalachia.
The pilot project, titled "Leveraging Generative Artificial Intelligence (AI) for Automated Climate Resilience Dashboards: A Case Study on Flood Monitoring in Central Appalachia," has recently secured $20,000 in funding from the Earth Science Information Partners (ESIP) Lab.
Dr. Qian Huang from ETSU’s Center for Rural Health and Research, in collaboration with Dr. ...
2024-12-04
With the help of an AI tool, computed tomography (CT) scans taken originally to look for tumors or bleeding or infections, also revealed calcium buildup in arteries, a sign of worsening cardiovascular disease.
This is the result of a new study led by researchers at NYU Langone Health and an example of a new trend in “opportunistic screening,” wherein radiologists repurpose existing medical images to diagnose illnesses beyond what the scan was originally designed to find.
Presented at the annual Radiological Society of North America ...
2024-12-04
Nativity—characterized by place of birth, duration of residence in the host country, citizenship and immigration status—greatly influences the health of foreign-born individuals in the United States (U.S.). Despite this, many national health surveys omit questions about these dimensions of nativity, particularly immigration status. This omission limits the ability to assess health disparities across diverse immigrant subgroups and develop evidence-based policies and targeted interventions.
To navigate this limitation, researchers rely on proxy measures or imputations ...
2024-12-04
Physicians at the University of Oklahoma Health Sciences in Oklahoma City are leading a national clinical trial to help women with polycystic ovary syndrome (PCOS)-related infertility who want to become pregnant.
The trial, called REBALANCE, studies the safety and effectiveness of an investigational device developed by May Health that is designed to restore ovulation disrupted by PCOS. OU Health reproductive endocrinologist Karl Hansen, M.D., Ph.D., chair of the Department of Obstetrics and Gynecology at the OU College of Medicine, is leading the trial for ...
2024-12-04
An experimental bacteria-derived biopesticide is highly effective in killing malaria-carrying mosquitoes, including those that have developed resistance to chemical pesticides, according to initial field tests led by researchers at the Johns Hopkins Bloomberg School of Public Health.
The biopesticide is a powder made from the dead cells of a common soil-dwelling bacterial species. The researchers showed that the biopesticide efficiently kills both ordinary and chemical-pesticide-resistant mosquitoes when included in standard baits. ...
2024-12-04
WINSTON-SALEM, N.C. – December 4, 2024 — The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has announced a groundbreaking investment of $2.5 million in the region’s regenerative medicine industry through its inaugural Ecosystem Building Grant program. This milestone underscores PTRME’s leadership in regenerative medicine and commitment to positioning the Piedmont Triad as a global hub for innovation. Six innovative companies have been awarded grants ...
2024-12-04
Images
EAST LANSING, Mich. – As global temperatures rise, it’s imperative that plants can adapt to new and changing conditions.
As global temperatures rise, it’s imperative that plants can adapt to new and changing conditions.
Michigan State University researchers from the Walker lab are looking at ways to give plants an assist. More specifically, their research aims to help plants adapt to changing temperatures by introducing engineered enzymes that will increase plants’ heat tolerance.
“I would say that the main goal of our research is to prepare plants for elevated temperatures because, with climate change, ...
2024-12-04
The Gerontological Society of America (GSA) — the country’s largest interdisciplinary organization devoted to the field of aging — is proud to acknowledge the work of 34 outstanding individuals through its prestigious awards program.
GSA salutes outstanding research, recognizes distinguished leadership in teaching and service, and fosters new ideas through a host of awards. Nominated by their peers, the recipients’ achievements serve as milestones in the history and development of gerontology.
The awardees were honored at various ...
LAST 30 PRESS RELEASES:
[Press-News.org] Abnormal prenatal blood test results could indicate hidden maternal cancers
NIH study finds some abnormal results due to colorectal, breast, lung and pancreatic cancers
